Skip links

Taffix

References

  1. Taffix – User instructions.
  2. Taffix Study Report. Acidity Tests in Porcine Nasal Tissues Following Taffix / Taffix Allergy Administration. TAF.STR.002. Formulex Pharma Innovations. 2021. (Data on file).
  3. Hull D, Rennie P, Noronha A, et al. Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold. Acta Otorhinolaryngol Ital. 2007;27(2):73-77.
  4. Taffix Study Report: TAFFI gel physical stability on nasal tissue. TAF.STR.001. Formulex Pharma Innovations. 2021. (Data on file)
  5. Gern JE, Mosser AG, Swenson CA, et al. Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline. J Infect Dis. 2007;195(8):1137-1143. doi:10.1086/512858.
  6. Waradon Sungnak, N. H.-L. (2020, May 26). SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine, 26, 681-687. Retrieved November 25, 2021, from http://www.nature.com/naturemedicine.
  7. Taffix protects cells from lentivirus infection. In vitro study, Nasus Pharma (Data on file).
  8. Rennie P, Bowtell P, Hull D, Charbonneau D, Lambkin-Williams R, Oxford J. Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection. Respir Res. 2007;8(1):38. Published 2007 May 17. doi:10.1186/1465-9921-8-38
  9. Taffix reduces cell death caused by H1N1 influenza virus by 90%. In vitro study, Formulex Pharma Innovations. (Data on file).
🍪 This website uses cookies to improve your web experience.